Menu
At OTAWA Health we are reshaping the landscape of oncology care through our Advanced Digital Oncology platform.
Our specialized Oncology Electronic Health Record and Clinical Decision Support system designed BY cancer care professionals FOR cancer care professionals, reshapes how cancer centers manage treatments while providing a comprehensive and coordinated patient care.
Our mission is focused in:
Born from the IT team of one of Brazil’s most respected oncology centers (www.cccancer.net), OTAWA Health proudly carries forward alegacy of excellence and innovation in oncology care.
Join us in our commitment to transform the future of cancer care. Your journey to better oncology management starts here.
Our journey began when the IT team at Centro de Combate ao Câncer (CCC) initiated the development of a specialized oncology EHR/CDS system for internal use.
The genesis of OTAWA Health took shape as we embarked on a project to emerge as an independent company from CCC.
Even before our official incorporation, Startup Health recognized us as a disruptor in the ‘End Cancer’ and ‘Cost to Zero’ moonshots, welcoming us into their Global Army of Health Transformers.
This year witnessed multiple successes.
We secured our second seed funding round and extended the use of OTWonco to two additional oncology centers.
We began the migration to a FHIR HL7 and HIPAA compliant cloud-based solution.
One achievement stood out as a testament to our commitment to social responsibility. In response to the COVID-19 pandemic, we voluntarily devoted our resources to a pro-bono effort – creating an AI platform to detect COVID-19 in chest x-ray images.
This platform was built to assist overwhelmed physicians in emergency rooms across the country. Our efforts were rewarded when AIIA won the “Artificial Intelligence against COVID-19” national challenge hosted by IdeiaGov, the innovation hub of the Government of the State of São Paulo, and by InRad, the radiology department of Hospital das Clínicas.
Our growth continued as we extended our services to five oncology centers.
OTAWA Health also entered into a partnership to introduce OTWonco to Rwanda and other Eastern African Community countries, bringing our innovative solutions to a combined population of 200 million in Africa.
The in-house developed system at CCC took full control of cancer care management, marking a major milestone in our healthcare innovation journey.
The year marked our official spin-off from CCC in late December.
Our in-house developed oncology EHR/CDS earned the names OTWonco and OTWdecision.
We also raised our first external seed funding round.
We expanded our reach to four oncology centers and were selected as a UCSF Health Hub Connected Company.
We also made our mark by being chosen for the 3rd USCF Health Awards “Breakthrough COVID-19 Technology”.
Signed a partnership with IQVIA Brasil which selected OTAWA Health as a data provider for oncology studies, recognizing the robustness of our Real-World Oncology Data
Our journey began when the IT team at Centro de Combate ao Câncer (CCC) initiated the development of a specialized oncology EHR/CDS system for internal use.
The genesis of OTAWA Health took shape as we embarked on a project to emerge as an independent company from CCC.
Even before our official incorporation, Startup Health recognized us as a disruptor in the ‘End Cancer’ and ‘Cost to Zero’ moonshots, welcoming us into their Global Army of Health Transformers.
This year witnessed multiple successes.
We secured our second seed funding round and extended the use of OTWonco to two additional oncology centers.
We began the migration to a FHIR HL7 and HIPAA compliant cloud-based solution.
One achievement stood out as a testament to our commitment to social responsibility. In response to the COVID-19 pandemic, we voluntarily devoted our resources to a pro-bono effort – creating an AI platform to detect COVID-19 in chest x-ray images.
This platform was built to assist overwhelmed physicians in emergency rooms across the country. Our efforts were rewarded when AIIA won the “Artificial Intelligence against COVID-19” national challenge hosted by IdeiaGov, the innovation hub of the Government of the State of São Paulo, and by InRad, the radiology department of Hospital das Clínicas.
The in-house developed system at CCC took full control of cancer care management, marking a major milestone in our healthcare innovation journey.
The year marked our official spin-off from CCC in late December.
Our in-house developed oncology EHR/CDS earned the names OTWonco and OTWdecision.
We also raised our first external seed funding round.
Our growth continued as we extended our services to five oncology centers.
OTAWA Health also entered into a partnership to introduce OTWonco to Rwanda and other Eastern African Community countries, bringing our innovative solutions to a combined population of 200 million in Africa.
We expanded our reach to four oncology centers and were selected as a UCSF Health Hub Connected Company.
We also made our mark by being chosen for the 3rd USCF Health Awards “Breakthrough COVID-19 Technology”.
Signed a partnership with IQVIA Brasil which selected OTAWA Health as a data provider for oncology studies, recognizing the robustness of our Real-World Oncology Data
Our journey began when the IT team at Centro de Combate ao Câncer (CCC) initiated the development of a specialized oncology EHR/CDS system for internal use.
The in-house developed system at CCC took full control of cancer care management, marking a major milestone in our healthcare innovation journey.
The genesis of OTAWA Health took shape as we embarked on a project to emerge as an independent company from CCC.
Even before our official incorporation, Startup Health recognized us as a disruptor in the ‘End Cancer’ and ‘Cost to Zero’ moonshots, welcoming us into their Global Army of Health Transformers.
The year marked our official spin-off from CCC in late December.
Our in-house developed oncology EHR/CDS earned the names OTWonco and OTWdecision.
We also raised our first external seed funding round.
This year witnessed multiple successes.
We secured our second seed funding round and extended the use of OTWonco to two additional oncology centers.
We began the migration to a FHIR HL7 and HIPAA compliant cloud-based solution.
One achievement stood out as a testament to our commitment to social responsibility. In response to the COVID-19 pandemic, we voluntarily devoted our resources to a pro-bono effort – creating an AI platform to detect COVID-19 in chest x-ray images.
This platform was built to assist overwhelmed physicians in emergency rooms across the country. Our efforts were rewarded when AIIA won the “Artificial Intelligence against COVID-19” national challenge hosted by IdeiaGov, the innovation hub of the Government of the State of São Paulo, and by InRad, the radiology department of Hospital das Clínicas.
We expanded our reach to four oncology centers and were selected as a UCSF Health Hub Connected Company.
We also made our mark by being chosen for the 3rd USCF Health Awards “Breakthrough COVID-19 Technology”.
Our growth continued as we extended our services to five oncology centers.
OTAWA Health also entered into a partnership to introduce OTWonco to Rwanda and other Eastern African Community countries, bringing our innovative solutions to a combined population of 200 million in Africa.
Signed a partnership with IQVIA Brasil which selected OTAWA Health as a data provider for oncology studies, recognizing the robustness of our Real-World Oncology Data
Our commitment goes beyond developing innovative technology. We strive to bring value to all stakeholders in the field of oncology, as well as to patients. Through the use of personalized diagnostic parameters and predefined treatment protocols using evidence-based medicine, we facilitate standardization of processes and procedures.
For patients, we aim to improve the overall quality and safety of treatment, contributing to better outcomes. For cancer centers, we provide tools for better management, treatment standardization, curated clinical decision support, and cost transparency, thereby reducing unjustified variability. For HMOs, our approach offers treatment cost transparency, predictability, and better managed cancer centers. For Pharma, we provide structured oncology Real-Word Data sets to support Real-World Evidence studies.
With every step we take, we remain committed to our mission: transforming cancer care and making a significant difference in the lives of patients and healthcare professionals. We envision a future where every cancer center can provide comprehensive, coordinated care underpinned by cutting-edge technology, and we’re working diligently to make this vision a reality.
A DIGITAL ONCOLOGY platform made of a specialized oncology-EHR/CDS solution created BY and FOR cancer care professionals.
OTAWA Health contributes to better management of cancer centers enabling a comprehensive and coordinated care while collecting structured oncology Real-World Data for Real-World Evidence studies to improve outcomes for patients with cancer.
We are a Brazilian health tech company based in São Paulo. Contact us here.